Journal article
Breast cancer risk in relation to the interval between menopause and starting hormone therapy.
- Abstract:
-
BACKGROUND: Although breast cancer risk is greater in users of estrogen-progestin than estrogen-only formulations of menopausal hormonal therapy, reports on their effects have been somewhat inconsistent. We investigated whether the timing of these therapies affected breast cancer incidence. METHODS: A total of 1,129,025 postmenopausal UK women provided prospective information on hormonal therapy use and other factors relevant for breast cancer risk. We used Cox regression to estimate adjusted...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Authors
Funding
Medical Research Council
More from this funder
Cancer Research UK
More from this funder
Bibliographic Details
- Publisher:
- Oxford University Press Publisher's website
- Journal:
- Journal of the National Cancer Institute Journal website
- Volume:
- 103
- Issue:
- 4
- Pages:
- 296-305
- Publication date:
- 2011-02-01
- DOI:
- EISSN:
-
1460-2105
- ISSN:
-
0027-8874
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:115748
- UUID:
-
uuid:1c45d2cd-8a07-4214-a3d4-4d536bd5d7c8
- Local pid:
- pubs:115748
- Source identifiers:
-
115748
- Deposit date:
- 2012-12-19
Terms of use
- Copyright holder:
- Beral et al
- Copyright date:
- 2011
- Notes:
- Copyright © 2011 Beral et al. Published by Oxford University Press. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
Metrics
If you are the owner of this record, you can report an update to it here: Report update to this record